UConn studies ways to improve HIV patient lives
Two NIH-funded study programs at UConn School of Medicine are studying ways to promote HIV testing and to improve the lives of people living with...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Two NIH-funded study programs at UConn School of Medicine are studying ways to promote HIV testing and to improve the lives of people living with...
Alexion Pharmaceuticals is planning to initiate a pivotal Phase 3 study of ULTOMIRIS® (ravulizumab) in amyotrophic lateral sclerosis (ALS). The 50-week global study, called CHAMPION-ALS,...
Hyperfine Research is pioneering a portable, point-of-care MRI it plans to market later this year for around $50,000, a fraction of the price of conventional...
About 50% of human DNA today is made of duplicated sequences that are the remnants of transposition events that took place in our evolutionary history....
Bayer and Azitra have announced a joint development agreement to collaborate in the identification and characterization of skin microbiome bacteria. The partnership will leverage Azitra’s...
SpringWorks Therapeutics has entered into a clinical trial collaboration agreement with Allogene Therapeutics.. This agreement will evaluate ALLO-715, Allogene’s investigational anti-B-cell maturation antigen (BCMA) AlloCAR...
Cybrexa Therapeutics has announced CBX-12 (alphalexTM-exatecan) as its new lead development program. CBX-12 is an alphalexTM conjugate that includes the highly potent topoisomerase I inhibitor exatecan. CBX-12...
IsoPlexis has raised an additional $20 million in its Series C financing, bringing the entire Series C round to $45 million. The funding will continue to...
ReNetX Bio reports that the FDA has granted the company Fast Track Designation for ReNetX Bio’s clinical therapy (AXER-204) for the potential treatment of Chronic Spinal...
Gary Mathias, Co-Founder and CEO of Thetis Pharmaceuticals, recently shared the following message. Happy New Year from the Thetis team! I am glad to report...